Background: Tissue remodeling is a crucial characteristic of chronic rhinosinusitis (CRS). Imbalance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) is crucial for the pathologic tissue remodeling in CRS. Elevation of interleukin (IL)-19 or MMP-9 levels in patients with CRS had been proven in previous studies. Here, we aimed to investigate the role of IL-19 in mediating MMP-9 expression in CRS.

Methods: Nasal tissue samples were collected from 45 individuals having chronic rhinosinusitis with nasal polyps (CRSwNP), 24 CRS without nasal polyps (CRSsNP), and 17 controls. Expression of IL-19, its receptors (IL-20R1/IL-20R2), and MMP-9 were investigated using RT-qPCR and Immunofluorescence (IF). Human nasal epithelial cells (HNECs) were stimulated by IL-19; ERK phosphorylation, nuclear factor-κB (NF-κB) pathway activation, and MMP-9 level were detected by RT-qPCR, enzyme-linked immunosorbent assay, western blot, and IF. We also explored the effect of type1/2/3 cytokines on IL-19 production by RT-qPCR, and western blot.

Results: Expression levels of IL-19, its receptors (IL-20R1/IL-20R2), and MMP-9 were increased in nasal tissues from individuals with CRSwNP compared to those with CRSsNP as well as the controls. IL-19 significantly elevated the production of MMP-9 in HNECs. Furthermore, IL-19 could activate the ERK and NF-κB pathways, accompanied by increased MMP-9 production in HNECs. Conversely, both ERK and NF-κB inhibitors significantly attenuated the role of IL-19 in MMP-9 production. siRNA knockdown of IL-20R1 suppressed ERK and NF-κB pathway activation, thereby decreasing MMP-9 expression. IL-13 and IL-17A were found to stimulate IL-19 production in HNECs.

Conclusion: IL-19, promoted by IL-13 and IL-17A, contributes to the upregulation of secretion of the tissue remodeling factor MMP-9 in patients with CRS.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099262PMC
http://dx.doi.org/10.1002/clt2.12003DOI Listing

Publication Analysis

Top Keywords

il-19
12
chronic rhinosinusitis
12
mmp-9 expression
12
tissue remodeling
12
erk nf-κb
12
mmp-9
11
il-19 mmp-9
8
patients crs
8
role il-19
8
nasal polyps
8

Similar Publications

Purpose: In this study, we aimed to investigate the relationship between the intraocular levels of inflammatory factors and myopia-related retinal vascular and neuronal degeneration.

Patients And Methods: One hundred and forty-seven patients with Implantable Collamer Lens (ICL) implantation were enrolled and all participants received comprehensive ophthalmic examination. About 100~150 ul of aqueous humor was collected immediately before ICL surgery.

View Article and Find Full Text PDF
Article Synopsis
  • Psoriasis, a complicated skin condition linked to inflammation, has unclear connections between its severity, related cytokine levels, and heart disease risk.
  • This study aimed to identify serum markers to help monitor cardiovascular disease (CVD) risk in psoriasis patients by examining relationships between cytokines and coronary artery health.
  • Key findings highlight that specific cytokines (IL-17A, IL-19, IL-36) correlate with psoriasis severity, while markers like CD31 and resistin show promise for tracking coronary atherosclerosis progression, particularly in patients with psoriasis vulgaris.
View Article and Find Full Text PDF

Background: Psoriasis, a chronic, immune-mediated, inflammatory disease, affects 2‒3% of the population. Tyrosine kinase 2 (TYK2) mediates cytokine signaling involved in adaptive [interleukin (IL)-12, IL-23] and innate (type-I interferons) immune responses; IL-23-driven T-helper (Th)17 pathways play a key role in chronic inflammation in psoriasis. In a phase 2 trial, deucravacitinib, an oral, selective, allosteric TYK2 inhibitor, reduced IL-23/Th17 and type-I interferon pathway expression in the skin of patients with moderate to severe plaque psoriasis, reductions that were accompanied by clinical improvement of psoriatic lesions.

View Article and Find Full Text PDF
Article Synopsis
  • A thermosensitive hydrogel made with chitosan and black phosphorus nanosheets was created to combat multidrug-resistant bacteria and improve wound healing.
  • This hydrogel delivers an angiogenic drug, deferoxamine mesylate (DFO), which helps speed up cell migration and blood vessel formation.
  • When treated with near-infrared light, the hydrogel effectively kills bacteria and promotes a healing environment by boosting anti-inflammatory responses in macrophages.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the expression levels of IL-19 and IL-24 in patients with inflammatory bowel disease (IBD) compared to healthy controls, and how these levels change before and after biologic treatment.
  • Researchers measured IL-19 and IL-24 in intestinal tissue samples from 121 IBD patients and found elevated levels in IBD patients, with IL-19 being linked to disease activity after treatment.
  • The findings suggest that both IL-19 and IL-24 play significant roles in the inflammation associated with IBD and could potentially serve as biomarkers for tracking disease activity and treatment response.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!